Mohammadi Mohsen, Kiani Masood, Mehrabani Sanaz, Nikpour Maryam
Non-Communicable Pediatric Disease Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Caspian J Intern Med. 2022;13(Suppl 3):254-258. doi: 10.22088/cjim.13.0.254.
World Health Organization (WHO) declared COVID -19 infection a global pandemic. Children have milder disease than adults but different aspects of disease in children are not fully understood.
We describe 5 pediatric patients with COVID-19 that referred to Amirkola Children's Hospital, Babol, Iran. The youngest patient was 4 years old and the oldest was 12 years old. Three patients were males. None of the patients had a history of contacts with symptomatic patients with COVID -19. The most common symptoms included fever, cough, anorexia, weakness and diarrhea. One patient had gastrointestinal symptoms without respiratory symptoms. All patients had elevated ESR and CRP. Three of them had lymphopenia. RT-PCR was positive in all patients. Management included supportive care, antibiotics, antiviral treatment and hydroxychloroquine. All patients were discharged with good condition.
Children may have a variety of symptoms including respiratory or gastrointestinal symptoms. Mortality is rare in children and prognosis is better than the adults.
世界卫生组织（WHO）宣布新冠病毒感染为全球大流行。儿童感染新冠病毒后的病情比成人轻，但儿童新冠病毒感染疾病的不同方面尚未完全了解。
我们描述了5例转诊至伊朗巴博勒阿米尔科拉儿童医院的新冠病毒感染儿科患者。最年幼的患者4岁，最年长的12岁。3例为男性。所有患者均无接触新冠病毒感染症状患者的病史。最常见的症状包括发热、咳嗽、厌食、乏力和腹泻。1例患者有胃肠道症状但无呼吸道症状。所有患者血沉（ESR）和C反应蛋白（CRP）均升高。其中3例有淋巴细胞减少。所有患者逆转录聚合酶链反应（RT-PCR）均呈阳性。治疗包括支持治疗、抗生素、抗病毒治疗和羟氯喹。所有患者均康复出院。
儿童可能出现多种症状，包括呼吸道或胃肠道症状。儿童死亡率罕见，预后优于成人。
